首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CA9 Recombinant Antibody

Anti-Human CA9 Recombinant Antibody

产品编号

YR1222

别名

科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab
Catalog NumberYR1222
Molecular NameGirentuximab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundGirentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. Its development was suspended as a "naked" or unconjugated antibody during phase III trials due to efficacy.
CAS Number916138-87-9
ApplicationWB, FuncS, IF, Neut, ELISA, FCM, IP, PK, IHC, Activ
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCA9[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价